Mayo Clinic launches landmark study on rare neurological disease 

Every rare disease tells a story. Understanding how one unfolds — how it develops and evolves — is often the first step toward treating it. A small genetic error, a malfunctioning cell or a breakdown in a biological process can set disease in motion. But for many rare conditions, the course of progression remains unwritten.  A groundbreaking natural history study led by researchers at Mayo Clinic’s Center for Individualized Medicine and Department of Clinical Genomics aims to…

See also  Selumetinib shows Limited Efficacy in Treatment of cutaneous neurofibromatosis: JAMA
Total
0
Share
Need Help?